- Protease-Inhibitor (PI) Triple Therapy (TT) in Mildly Decompensated Cirrhotics: Predictors of Treatment Discontinuation, Worsening Decompensation and Sustained Virologic ResponseSaxena Varun; Yee Helen S; Catalli Lisa; Wayne Elizabeth M; Chua Joshua; Monto Alexander; Terrault Norah64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, 2013-11-01 To 2013-11-05.
- Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life SettingsDario, Cattaneo; Salvatore, Sollima; Paola, Meraviglia; Laura, Milazzo; Davide, Minisci; Marta, Fusi; Carlo, Filice; Cristina, GervasoniDRUGS IN R&D, 2020, 20(2): 155-160.
- Direct-acting antivirals trigger a favorable, sustained virological response in patients with chronic hepatitis C infections and hepatocellular carcinomaWon, SohnThe Korean Journal of Internal Medicine, 2021, 36(2): 286-287.
会议论文
Higher Sustained Virologic Response (SVR-12) Achievable in Liver Transplant (LT) Recipients with Hepatitis C (HCV) Treated with Protease Inhibitor (PI) Triple Therapy (TT)
3被引9阅读
